Literature DB >> 20732990

Eosinophils are dispensable for allergic remodeling and immunity in a model of house dust mite-induced airway disease.

Ramzi Fattouh1, Amal Al-Garawi, Marcia Fattouh, Katherine Arias, Tina D Walker, Susanna Goncharova, Anthony J Coyle, Alison A Humbles, Manel Jordana.   

Abstract

RATIONALE: Current thinking accredits eosinophils with preeminent contributions to allergic airway responses, including a major role in the development of airway remodeling, a process thought to significantly contribute to airway dysfunction. However, direct evidence in support of this notion is limited and often controversial.
OBJECTIVES: We elucidated the requirement for eosinophils in the generation of allergic sensitization, airway inflammation, and remodeling in a model involving chronic respiratory exposure to house dust mite (HDM).
METHODS: We used three methods to selectively eliminate eosinophils, a depleting antibody (anti-CCR3), and two strains of eosinophil-deficient mice (ΔdblGATA and the transgenic line PHIL).
MEASUREMENTS AND MAIN RESULTS: Anti-CCR3 treatment markedly reduced pulmonary eosinophilia (> 80%) over the course of HDM exposure but had no effect on the remaining inflammatory response, the extent of lung Th2 cells, or the development of remodeling-associated changes, including subepithelial collagen deposition and smooth muscle thickening. In addition, we observed that, despite the absence of eosinophils, HDM-exposed GATA mice mounted robust airway and lung inflammation and hyperresponsiveness and showed a remodeling response equivalent to that observed in wild-type mice. Moreover, these mice had similar serum HDM-specific IgE levels and Th2-associated splenocyte cytokine production as HDM-exposed wild-type control mice. Similar observations were made in PHIL eosinophil-deficient mice subjected to chronic HDM exposure, although slight decreases in airway mononuclear cells, but not lung Th2 cells, and remodeling were noted.
CONCLUSIONS: Collectively, these data demonstrate that, at variance with the prevailing paradigm, eosinophils play negligible roles in the generation of HDM-induced allergic immunity and airway remodeling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20732990     DOI: 10.1164/rccm.200905-0736OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  29 in total

Review 1.  Update in asthma 2011.

Authors:  Shamsah Kazani; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2012-07-01       Impact factor: 21.405

2.  Treatment of experimental asthma using a single small molecule with anti-inflammatory and BK channel-activating properties.

Authors:  Monica P Goldklang; Jose F Perez-Zoghbi; Jordis Trischler; Takwi Nkyimbeng; Sergey I Zakharov; Takayuki Shiomi; Tina Zelonina; Andrew R Marks; Jeanine M D'Armiento; Steven O Marx
Journal:  FASEB J       Date:  2013-08-30       Impact factor: 5.191

3.  The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling.

Authors:  Taylor A Doherty; Pejman Soroosh; Naseem Khorram; Satoshi Fukuyama; Peter Rosenthal; Jae Youn Cho; Paula S Norris; Heonsik Choi; Stefanie Scheu; Klaus Pfeffer; Bruce L Zuraw; Carl F Ware; David H Broide; Michael Croft
Journal:  Nat Med       Date:  2011-04-17       Impact factor: 53.440

4.  Eosinophils in the spotlight: Finding the link between obesity and asthma.

Authors:  Clare M Lloyd; Sejal Saglani
Journal:  Nat Med       Date:  2013-08       Impact factor: 53.440

5.  Eosinophils contribute to the resolution of lung-allergic responses following repeated allergen challenge.

Authors:  Katsuyuki Takeda; Yoshiki Shiraishi; Shigeru Ashino; Junyan Han; Yi Jia; Meiqin Wang; Nancy A Lee; James J Lee; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2014-10-11       Impact factor: 10.793

Review 6.  Synergy of Interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases.

Authors:  Hemanth Kumar Kandikattu; Sathisha Upparahalli Venkateshaiah; Anil Mishra
Journal:  Cytokine Growth Factor Rev       Date:  2019-05-10       Impact factor: 7.638

7.  The immunology of asthma.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

8.  Frontline Science: Eosinophil-deficient MBP-1 and EPX double-knockout mice link pulmonary remodeling and airway dysfunction with type 2 inflammation.

Authors:  Sergei I Ochkur; Alfred D Doyle; Elizabeth A Jacobsen; William E LeSuer; Wen Li; Cheryl A Protheroe; Katie R Zellner; Dana Colbert; HuaHao H Shen; Charlie G Irvin; James J Lee; Nancy A Lee
Journal:  J Leukoc Biol       Date:  2017-05-17       Impact factor: 4.962

Review 9.  Re-defining the unique roles for eosinophils in allergic respiratory inflammation.

Authors:  E A Jacobsen; N A Lee; J J Lee
Journal:  Clin Exp Allergy       Date:  2014-09       Impact factor: 5.018

10.  PARP inhibition treatment in a nonconventional experimental mouse model of chronic asthma.

Authors:  Raffaela Zaffini; Rosanna Di Paola; Salvatore Cuzzocrea; Marta Menegazzi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.